Skip to main content

Table 3 Multivariate analysis of variables predictive of PFS and OS

From: Nomograms based on SUVmax of 18F-FDG PET/CT and clinical parameters for predicting progression-free and overall survival in patients with newly diagnosed extranodal natural killer/T-cell lymphoma

 

PFS

OS

Variables

HR (95% CI)

P value

HR (95% CI)

P value

Ann Arbor stage

 I

Reference

 

Reference

 

 II

1.348 (0.730–2.489)

0.340

1.448 (0.670–3.128)

0.347

 III-IV

2.035 (1.098–3.771)

0.024

2.499 (1.169–5.342)

0.018

B symptoms (No vs. Yes)

1.031 (0.636–1.673)

0.901

1.011 (0.567–1.802)

0.971

LDH (Normal vs. Elevated)

1.605 (0.962–2.679)

0.070

1.971 (1.057–3.677)

0.033

β2-MG (Normal vs. Elevated)

1.744 (1.114–2.731)

0.015

1.894 (1.099–3.264)

0.022

Hb (< 120 g/L vs. ≥120 g/L)

1.533 (0.937–2.507)

0.089

1.328 (0.754–2.341)

0.326

SUVmax (≤9.5 vs. > 9.5)

1.778 (1.026–3.079)

0.040

2.192 (1.064–4.514)

0.033

  1. Abbreviations: CI confidence interval, HR hazard ratio, PFS progression-free survival, OS overall survival, LDH lactate dehydrogenase, β2-MG β2-microglobulin, Hb hemoglobin